Senior insider sale
See "Remarks" at TEVA PHARMACEUTICAL INDUSTRIES LTD — senior position signals high conviction
$1.87M
62.10K shares
What this filing means
SABAG MARK plans to sell 62.10K shares of TEVA PHARMACEUTICAL INDUSTRIES LTD valued at approximately $1.87M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 3/17/2026ACC: 0001973379-26-000116
Officer· See "Remarks"
Since Mar 2026
62.10K
Shares to sell
$1.87M
Approx. market value
62.10K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months3
SHARES FROM ROLLOVER
COMPENSATION
3/4/2026
18.60KSHARES FROM ROLLOVER
COMPENSATION
3/3/2026
24.90KSHARES FROM ROLLOVER
COMPENSATION
3/4/2025
18.60KTotal acquired62.10K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
3/4/2026 | SHARES FROM ROLLOVER COMPENSATION | 18.60K | — |
3/3/2026 | SHARES FROM ROLLOVER COMPENSATION | 24.90K | — |
3/4/2025 | SHARES FROM ROLLOVER COMPENSATION | 18.60K | — |
| Total | 62.10K | ||
Planned & Completed Dispositions1
NYSEPlanned
Units to sell
62.10K
Market value
$1.87M
3/17/2026
Total
Units
62.10K
Value
$1.87M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
3/17/2026 | 62.10K | $1.87M | NYSE | Planned |
| Total | 62.10K | $1.87M | ||